Cybin Inc. Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
E Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
Article By: Lorimer Wilson
Sunday, January 9, 2022 7:57 PM EST
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index, which is now -65.9% from its 2021 highs. Here are the details for each constituent.
In this article: MNMD, ZYNE, CRBP, SEEL, DMTTF, CYBN, FTRP, NUMIF
Read
E Psychedelic Drug Stocks Have Plunged -10.6%, On Average, So Far In November
Article By: Lorimer Wilson
Sunday, November 14, 2021 11:38 PM EST
Our Pure-Play Psychedelic Compounds-Based Drug Stocks Index has declined -10.6% in the last 2 weeks; it's still up +7.8% since the end of September.
In this article: ATAI, MYCOF, CYBN, AWKNF
Read
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
Article By: Jeff Nielson
Saturday, October 23, 2021 7:03 AM EST
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.
In this article: CMPS, NVMDF, DMTTF, CYBN, FTRP, LVTTF
Read
E Magic Mushroom Drug Stock Performances YTD
Article By: Lorimer Wilson
Saturday, August 28, 2021 11:39 PM EST
Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.
In this article: MNMD, CMPS, MYCOF, CYBN
Read

Latest Tweets for $CYBN

No tweets yet!

PARTNER HEADLINES